The risk of mortality from multiple primary cancers in colorectal cancer survivors: analysis of data from the South Australian Cancer Registry.

IF 2.8 3区 医学 Q3 ONCOLOGY
Mulugeta Melku, Oliver G Best, Jean M Winter, Lauren A Thurgood, Ganessan Kichenadasse, Molla M Wassie, Muktar Ahmed, Erin L Symonds
{"title":"The risk of mortality from multiple primary cancers in colorectal cancer survivors: analysis of data from the South Australian Cancer Registry.","authors":"Mulugeta Melku, Oliver G Best, Jean M Winter, Lauren A Thurgood, Ganessan Kichenadasse, Molla M Wassie, Muktar Ahmed, Erin L Symonds","doi":"10.1007/s00432-025-06268-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Colorectal cancer (CRC) survivors face an increased risk of multiple primary cancers (MPCs), but evidence on MPC-related mortality is limited.</p><p><strong>Methods: </strong>Using data from the South Australian Cancer Registry (1982-2017), this retrospective study analysed CRC survivors diagnosed with MPCs, defined as distinct primary cancers arising ≥ 2 months after CRC diagnosis. Causes of death were categorised as index CRC, MPC, or non-cancer related. Poisson regression estimated cancer-specific mortality risk compared to the general population. Propensity score weighting was applied to balance covariate distribution between CRC survivors with and without MPC groups. A hazard ratio (HR) for all-cause mortality was estimated using a weighted dataset to assess the impact of MPC on overall survival.</p><p><strong>Results: </strong>Among 26,093 CRC survivors (181,877 person-years follow-up), the age-standardised MPC-related mortality rate was 240 per 100,000 population. Gastrointestinal, lung, haematological, and urinary tract cancers were the most common MPC-related causes of death. CRC survivors had a 45% higher risk of dying from MPCs than the general population (standardised mortality ratio = 1.45, 95%CI 1.38-1.52). Adjusted analyses showed a 58% increase in all-cause mortality among CRC survivors with MPCs (HR = 1.58, 95%CI 1.51-1.65).</p><p><strong>Conclusions: </strong>CRC survivors with MPC face significantly worse survival compared to those with a single primary CRC. Early detection and management of MPCs are essential for improving long-term survival in individuals diagnosed with CRC.</p>","PeriodicalId":15118,"journal":{"name":"Journal of Cancer Research and Clinical Oncology","volume":"151 7","pages":"222"},"PeriodicalIF":2.8000,"publicationDate":"2025-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12297194/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Research and Clinical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00432-025-06268-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Colorectal cancer (CRC) survivors face an increased risk of multiple primary cancers (MPCs), but evidence on MPC-related mortality is limited.

Methods: Using data from the South Australian Cancer Registry (1982-2017), this retrospective study analysed CRC survivors diagnosed with MPCs, defined as distinct primary cancers arising ≥ 2 months after CRC diagnosis. Causes of death were categorised as index CRC, MPC, or non-cancer related. Poisson regression estimated cancer-specific mortality risk compared to the general population. Propensity score weighting was applied to balance covariate distribution between CRC survivors with and without MPC groups. A hazard ratio (HR) for all-cause mortality was estimated using a weighted dataset to assess the impact of MPC on overall survival.

Results: Among 26,093 CRC survivors (181,877 person-years follow-up), the age-standardised MPC-related mortality rate was 240 per 100,000 population. Gastrointestinal, lung, haematological, and urinary tract cancers were the most common MPC-related causes of death. CRC survivors had a 45% higher risk of dying from MPCs than the general population (standardised mortality ratio = 1.45, 95%CI 1.38-1.52). Adjusted analyses showed a 58% increase in all-cause mortality among CRC survivors with MPCs (HR = 1.58, 95%CI 1.51-1.65).

Conclusions: CRC survivors with MPC face significantly worse survival compared to those with a single primary CRC. Early detection and management of MPCs are essential for improving long-term survival in individuals diagnosed with CRC.

Abstract Image

结直肠癌幸存者多原发癌症的死亡风险:来自南澳大利亚癌症登记处的数据分析
目的:结直肠癌(CRC)幸存者面临多原发癌症(mpc)的风险增加,但mpc相关死亡率的证据有限。方法:使用南澳大利亚癌症登记处(1982-2017)的数据,本回顾性研究分析了诊断为MPCs的结直肠癌幸存者,MPCs定义为结直肠癌诊断后≥2个月出现的不同原发癌症。死亡原因被分类为指数CRC、MPC或非癌症相关。泊松回归估计了与一般人群相比的癌症特异性死亡风险。倾向评分加权用于平衡有和没有MPC组的CRC幸存者之间的协变量分布。使用加权数据集估计全因死亡率的风险比(HR),以评估MPC对总生存率的影响。结果:在26,093例结直肠癌幸存者(181,877人年随访)中,年龄标准化的mpc相关死亡率为每10万人240例。胃肠道、肺部、血液学和泌尿道癌症是最常见的与mpc相关的死亡原因。结直肠癌幸存者死于MPCs的风险比一般人群高45%(标准化死亡率= 1.45,95%CI 1.38-1.52)。校正分析显示,合并MPCs的结直肠癌幸存者的全因死亡率增加58% (HR = 1.58, 95%CI 1.51-1.65)。结论:与单发原发性结直肠癌患者相比,伴有MPC的结直肠癌患者的生存期明显更差。早期发现和管理MPCs对于改善CRC患者的长期生存至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.00
自引率
2.80%
发文量
577
审稿时长
2 months
期刊介绍: The "Journal of Cancer Research and Clinical Oncology" publishes significant and up-to-date articles within the fields of experimental and clinical oncology. The journal, which is chiefly devoted to Original papers, also includes Reviews as well as Editorials and Guest editorials on current, controversial topics. The section Letters to the editors provides a forum for a rapid exchange of comments and information concerning previously published papers and topics of current interest. Meeting reports provide current information on the latest results presented at important congresses. The following fields are covered: carcinogenesis - etiology, mechanisms; molecular biology; recent developments in tumor therapy; general diagnosis; laboratory diagnosis; diagnostic and experimental pathology; oncologic surgery; and epidemiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信